Palisade Bio Income Statement (2010-2026) | PALI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)								0.25M
Operating items
Research & Development (Quarter)	0.31M	0.62M	0.80M	0.96M	1.32M	1.93M	2.34M	1.24M	2.18M	2.10M	0.36M	2.21M	2.63M	16.00M	2.08M	0.95M	1.68M	1.39M	6.17M	6.00M
Selling, General & Administrative (Quarter)	2.43M	2.39M	3.23M	2.93M	2.25M	2.08M	1.50M	1.54M	1.43M	1.67M	1.56M	1.46M	1.58M	1.46M	1.30M	1.36M	1.17M	1.53M	3.81M	4.35M
Restructuring Costs (Quarter)												1.38M	1.48M	1.24M	1.38M	1.35M	1.14M	1.52M	3.57M	4.22M
Other Operating Expenses (Quarter)	30.12M					0.41M					1.23M	-1.38M	-1.48M	-15.10M	-1.38M	-1.35M	-1.14M	-1.52M	-3.57M	-3.82M
Operating Expenses (Quarter)	32.86M	3.02M	4.03M	3.89M	3.57M	4.41M	3.85M	2.78M	3.61M	3.78M	3.15M	3.67M	4.21M	3.59M	3.38M	2.31M	2.84M	2.92M	9.98M	10.75M
Operating Income (Quarter)	-32.86M	-3.02M	-4.03M	-3.89M	-3.57M	-4.41M	-3.85M	-2.53M	-3.61M	-3.78M	-3.15M	-3.67M	-4.21M	-3.59M	-3.38M	-2.31M	-2.84M	-2.92M	-9.98M	-10.75M
EBIT (Quarter)	-32.86M	-3.02M	-4.03M	-3.89M	-3.57M	-4.41M	-3.85M	-2.53M	-3.61M	-3.78M	-3.15M	-3.67M	-4.21M	-3.59M	-3.38M	-2.31M	-2.84M	-2.92M	-9.98M	-10.75M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	5.13M	12.76M		0.79M	1.23M	0.43M	0.13M	0.19M	0.22M	0.19M	0.19M	0.15M	0.13M	0.11M	0.04M	0.08M	0.06M	0.06M	1.08M	1.15M
Non Operating Income (Quarter)	0.02M	11.10M	5.10M	-0.32M	1.23M	0.42M	0.13M	0.19M	0.22M	0.18M	0.18M	0.15M	0.13M	0.11M	0.04M	0.08M	0.06M	0.06M	1.07M	1.15M
Net income details
EBT (Quarter)	-33.51M	-3.04M	-4.03M	-3.89M	-3.58M	-4.42M	-3.85M	-2.53M	-3.61M	-3.79M	-3.16M	-3.67M	-4.21M	-3.60M	-3.38M	-2.31M	-2.85M	-2.93M	-9.98M	-10.75M
Profit After Tax (Quarter)	-31.75M	8.09M	1.07M	-4.21M	-2.34M	-3.99M	-3.72M	-2.34M	-3.39M	-3.60M	-2.97M	-3.53M	-4.08M	-3.49M	-3.34M	-2.23M	-2.78M	-2.87M	-8.90M	-9.60M
Income from Continuing Operations (Quarter)	-33.51M	-3.04M	-4.03M	-3.89M	-3.58M	-4.42M	-3.85M	-2.53M	-3.61M	-3.79M	-3.16M	-3.67M	-4.21M	-3.60M	-3.38M	-2.31M	-2.85M	-2.93M	-9.98M	-10.75M
Consolidated Net Income (Quarter)	-33.51M	-3.04M	-4.03M	-3.89M	-3.58M	-4.42M	-3.85M	-2.53M	-3.61M	-3.79M	-3.16M	-3.67M	-4.21M	-3.60M	-3.38M	-2.31M	-2.85M	-2.93M	-9.98M	-10.75M
Income towards Parent Company (Quarter)	-33.51M	-3.04M	-4.03M	-3.89M	-3.58M	-4.42M	-3.85M	-2.53M	-3.61M	-3.79M	-3.16M	-3.67M	-4.21M	-3.60M	-3.38M	-2.31M	-2.85M	-2.93M	-9.98M	-10.75M
Net Income towards Common Stockholders (Quarter)	-31.75M	5.12M	6.19M	-3.89M	-2.34M	-4.42M	-3.85M	-2.34M	-3.39M	-3.79M	-3.16M	-3.53M	-4.08M	-3.49M	-3.38M	-2.23M	-2.78M	-2.87M	-9.98M	-10.75M
Additional items
EPS (Basic) (Quarter)	-3.59	0.42	-139.45	-12.96	-5.77	-4.10	1.87	-8.13	-7.93	-7.38	-3.77	-4.59	-3.32	-2.32	-0.69	-0.47	-0.58	-0.38	1.08	-0.05
EPS (Weighted Average and Diluted) (Quarter)	-4.10	0.42	-165.61	-12.96	-5.77	-4.10	1.87	-8.13	-7.93	-7.38	-3.77	-4.59	-3.32	-2.32	-0.69	-0.47	-0.58	-0.38	1.08	-0.05
Shares Outstanding (Weighted Average) (Quarter)	5.80M	7.90M	0.19M	0.32M	0.41M	0.57M	0.88M	0.29M	0.43M	0.40M	0.46M	0.77M	1.00M	1.17M	1.42M	4.80M	4.80M	5.70M	64.03M	209.66M
Shares Outstanding (Diluted Average) (Quarter)		12.11M		0.32M	0.41M	0.97M	0.88M	0.29M	0.36M	0.49M	0.46M	0.77M	1.00M	1.17M	1.42M	4.80M	4.80M	5.70M	55.67M	209.66M
EBITDA (Quarter)	-32.86M	-3.02M	-4.03M	-3.89M	-3.57M	-4.41M	-3.85M	-2.53M	-3.61M	-3.78M	-3.15M	-3.67M	-4.21M	-3.59M	-3.38M	-2.31M	-2.84M	-2.92M	-9.98M	-10.75M
Interest Expenses (Quarter)	0.66M	0.03M	0.01M	0.00M	0.01M	0.00M	0.00M		0.00M	0.01M	0.00M	0.00M	0.00M	0.01M	0.00M	0.00M	0.00M	0.01M	0.00M	0.00M

Research Tools

Developers

Palisade Bio Income Statement (2010-2026) | PALI

Research Tools

Developers

Palisade Bio Income Statement (2010-2026) | PALI

Create an account

Sign In

Reset Password